Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia
Objective: The objective of the present work is to investigate the clinical outcomes related to cognitive performance in Colombian patients with DBS treatment. Background: Parkinson's…Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)
Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson's disease (PD). Background: The observed heterogeneity of cognitive function in…Development and Feasibility Trial of iSupport-PD, a Digital intervention for carers of people with Parkinson’s and Cognitive Impairment
Objective: Develop a digital intervention to prevent or decrease the mental and physical health problems associated with caring and improve quality of life of carers…Neurovascular Involvement in Parkinson’s Disease Cognitive Impairment: A 4D Flow Study
Objective: To investigate the cerebrovascular contribution to cognitive decline in Parkinson’s disease (PD). Background: Cognitive impairment is a major non-motor feature of PD. Accruing evidence…Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease
Objective: To investigate the presence of beta-amyloid pathology in Huntington's disease (HD) and its potential impact on patients' cognitive status. Background: Recent evidence indicates that…Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease
Objective: To assess whether including measurements of neuroimaging and biofluid-based biomarkers improves predictive ability of models of motor and non-motor progression up to 5-year follow-up…Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.
Objective: To verify whether connectivity changes in the dorsolateral prefrontal cortex (DLPC) and the precuneus (PCun) can predict cognitive phenotypes in de novo Parkinson’s disease…Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease
Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…Apathy produces selective deficits in cognitive function when controlling for depression in patients with Parkinson’s disease
Objective: To compare differences in the mean cognitive impairment (CI) of patients with and without clinically significant apathy in PD, PD-mild cognitive impairment (PD-MCI), and…Parkinson’s Disease (PD) and predictors of Driving Cessation: Results from a 6-year Longitudinal Study and a systematic review of the literature
Objective: We sought to identify predictors of driving cessation among PD patients. Background: Motor and cognitive impairment of PD patients interfere with their driving ability.…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 117
- Next Page »